Literature DB >> 25709026

Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer.

Daniel P Nguyen1, Bashir Al Hussein Al Awamlh2, Xian Wu3, Padraic O'Malley2, Igor M Inoyatov2, Abimbola Ayangbesan2, Bishoy M Faltas4, Paul J Christos3, Douglas S Scherr2.   

Abstract

BACKGROUND: Concerns remain whether robot-assisted radical cystectomy (RARC) compromises survival because of inadequate oncologic resection or alteration of recurrence patterns.
OBJECTIVE: To describe recurrence patterns following open radical cystectomy (ORC) and RARC. DESIGN, SETTING, AND PARTICIPANTS: Retrospective review of 383 consecutive patients who underwent ORC (n=120) or RARC (n=263) at an academic institution from July 2001 to February 2014. INTERVENTION: ORC and RARC. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Recurrence-free survival estimates were illustrated using the Kaplan-Meier method. Recurrence patterns (local vs distant and anatomic locations) within 2 yr of surgery were tabulated. Cox regression models were built to evaluate the effect of surgical technique on the risk of recurrence. RESULTS AND LIMITATIONS: The median follow-up time for patients without recurrence was 30 mo (interquartile range [IQR] 5-72) for ORC and 23 mo (IQR 9-48) for RARC (p=0.6). Within 2 yr of surgery, there was no large difference in the number of local recurrences between ORC and RARC patients (15/65 [23%] vs 24/136 [18%]), and the distribution of local recurrences was similar between the two groups. Similarly, the number of distant recurrences did not differ between the groups (26/73 [36%] vs 43/147 [29%]). However, there were distinct patterns of distant recurrence. Extrapelvic lymph node locations were more frequent for RARC than ORC (10/43 [23%] vs 4/26 [15%]). Furthermore, peritoneal carcinomatosis was found in 9/43 (21%) RARC patients compared to 2/26 (8%) ORC patients. In multivariable analyses, RARC was not a predictor of recurrence. Limitations of the study include selection bias and a limited sample size.
CONCLUSIONS: Within limitations, we found that RARC is not an independent predictor of recurrence after surgery. Interestingly, extrapelvic lymph node locations and peritoneal carcinomatosis were more frequent in RARC than in ORC patients. Further validation is warranted to better understand the oncologic implications of RARC. PATIENT
SUMMARY: In this study, the locations of bladder cancer recurrences following conventional and robotic techniques for removal of the bladder are described. Although the numbers are small, the results show that the distribution of distant recurrences differs between the two techniques.
Copyright © 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Distant; Local; Open radical cystectomy; Recurrence; Robot-assisted radical cystectomy

Mesh:

Year:  2015        PMID: 25709026      PMCID: PMC4727829          DOI: 10.1016/j.eururo.2015.02.003

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  27 in total

1.  Surgical atlas. Radical cystectomy.

Authors:  John P Stein; Donald G Skinner
Journal:  BJU Int       Date:  2004-07       Impact factor: 5.588

Review 2.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

Authors:  J I Epstein; M B Amin; V R Reuter; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

3.  A randomized trial of robot-assisted laparoscopic radical cystectomy.

Authors:  Bernard H Bochner; Daniel D Sjoberg; Vincent P Laudone
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

4.  Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades.

Authors:  Pascal Zehnder; Urs E Studer; Eila C Skinner; George N Thalmann; Gus Miranda; Beat Roth; Jie Cai; Frédéric D Birkhäuser; Anirban P Mitra; Fiona C Burkhard; Ryan P Dorin; Siamak Daneshmand; Donald G Skinner; Inderbir S Gill
Journal:  BJU Int       Date:  2013-07       Impact factor: 5.588

5.  Patterns of metastasis in muscle-invasive bladder cancer (pT2-4): An autopsy study on 367 patients.

Authors:  A Wallmeroth; U Wagner; H Moch; T C Gasser; G Sauter; M J Mihatsch
Journal:  Urol Int       Date:  1999       Impact factor: 2.089

6.  Robotic-assisted radical cystectomy with extracorporeal urinary diversion for urothelial carcinoma of the bladder: analysis of complications and oncologic outcomes in 175 patients with a median follow-up of 3 years.

Authors:  Evanguelos Xylinas; David A Green; Brandon Otto; Asha Jamzadeh; Luis Kluth; Richard K Lee; Brian D Robinson; Shahrokh F Shariat; Douglas S Scherr
Journal:  Urology       Date:  2013-12       Impact factor: 2.649

7.  Robot-assisted radical cystectomy: description of an evolved approach to radical cystectomy.

Authors:  Justin W Collins; Stavros Tyritzis; Tommy Nyberg; Martin Schumacher; Oscar Laurin; Dinyar Khazaeli; Christofer Adding; Martin N Jonsson; Abolfazl Hosseini; N Peter Wiklund
Journal:  Eur Urol       Date:  2013-05-27       Impact factor: 20.096

8.  Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.

Authors:  Kristin M Sanderson; Jie Cai; Gustavo Miranda; Donald G Skinner; John P Stein
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

9.  Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.

Authors:  Zohar A Dotan; Kathryn Kavanagh; Ofer Yossepowitch; Matt Kaag; Semra Olgac; Machele Donat; Harry W Herr
Journal:  J Urol       Date:  2007-10-22       Impact factor: 7.450

10.  Long-term outcomes of robot-assisted radical cystectomy for bladder cancer.

Authors:  Muhammad Shamim Khan; Oussama Elhage; Benjamin Challacombe; Declan Murphy; Bola Coker; Peter Rimington; Timothy O'Brien; Prokar Dasgupta
Journal:  Eur Urol       Date:  2013-01-11       Impact factor: 20.096

View more
  40 in total

1.  Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis.

Authors:  Takehiro Iwata; Shoji Kimura; Beat Foerster; Nicola Fossati; Alberto Briganti; Pierre I Karakiewicz; Kilian M Gust; Shin Egawa; Yasutomo Nasu; Mohammad Abufaraj; Shahrokh F Shariat
Journal:  World J Urol       Date:  2019-04-11       Impact factor: 4.226

2.  Intra-corporeal robot-assisted versus open radical cystectomy: a propensity score-matched analysis comparing perioperative and long-term survival outcomes and recurrence patterns.

Authors:  Kenji Zennami; Makoto Sumitomo; Kiyoshi Takahara; Takuhisa Nukaya; Masashi Takenaka; Kosuke Fukaya; Manabu Ichino; Naohiko Fukami; Hitomi Sasaki; Mamoru Kusaka; Ryoichi Shiroki
Journal:  Int J Clin Oncol       Date:  2021-05-19       Impact factor: 3.402

3.  Surgical control and margin status after robotic and open cystectomy in high-risk cases: Caution or equivalence?

Authors:  Pranav Sharma; Kamran Zargar-Shoshtari; Michael A Poch; Julio M Pow-Sang; Wade J Sexton; Philippe E Spiess; Scott M Gilbert
Journal:  World J Urol       Date:  2016-08-05       Impact factor: 4.226

4.  Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study.

Authors:  Andrea Necchi; Gregory R Pond; Marc C Smaldone; Sumanta K Pal; Kevin Chan; Yu-Ning Wong; Rosalia Viterbo; Guru Sonpavde; Lauren C Harshman; Simon Crabb; Ajjai Alva; Simon Chowdhury; Ugo De Giorgi; Sandy Srinivas; Neeraj Agarwal; Aristotelis Bamias; Jack Baniel; Ali-Reza Golshayan; Sylvain Ladoire; Cora N Sternberg; Linda Cerbone; Evan Y Yu; Joaquim Bellmunt; Ulka Vaishampayan; Gunter Niegisch; Syed Hussain; Daniel W Bowles; Rafael Morales-Barrera; Matthew I Milowsky; Christine Theodore; Dominik R Berthold; Srikala S Sridhar; Thomas Powles; Jonathan E Rosenberg; Matthew D Galsky
Journal:  Eur Urol Focus       Date:  2017-03-31

5.  [Correlation between oncological outcome and surgical expertise].

Authors:  T Kälble
Journal:  Urologe A       Date:  2020-12       Impact factor: 0.639

6.  Case series - Peritoneal and port-site metastasis following roboticassisted radical prostatectomy.

Authors:  Ellen O'Connor; Brennan Timm; Bodie Chislett; Jiasian Teh; Nathan Lawrentschuk; Declan G Murphy; Damien Bolton
Journal:  Can Urol Assoc J       Date:  2021-01       Impact factor: 1.862

7.  Are we really seeking for equivalence?-The virtue of the robot is in technology.

Authors:  Aldo Brassetti; Riccardo Mastroianni; Giuseppe Simone
Journal:  Transl Androl Urol       Date:  2019-12

8.  Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes.

Authors:  Bernard H Bochner; Guido Dalbagni; Karim H Marzouk; Daniel D Sjoberg; Justin Lee; Sheri M Donat; Jonathan A Coleman; Andrew Vickers; Harry W Herr; Vincent P Laudone
Journal:  Eur Urol       Date:  2018-05-18       Impact factor: 20.096

9.  Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup.

Authors:  Vivek Venkatramani; Isildinha M Reis; Erik P Castle; Mark L Gonzalgo; Michael E Woods; Robert S Svatek; Alon Z Weizer; Badrinath R Konety; Mathew Tollefson; Tracey L Krupski; Norm D Smith; Ahmad Shabsigh; Daniel A Barocas; Marcus L Quek; Atreya Dash; Adam S Kibel; Raj S Pruthi; Jeffrey Scott Montgomery; Christopher J Weight; David S Sharp; Sam S Chang; Michael S Cookson; Gopal N Gupta; Alex Gorbonos; Edward M Uchio; Eila Skinner; Nachiketh Soodana-Prakash; Maria F Becerra; Sanjaya Swain; Kerri Kendrick; Joseph A Smith; Ian M Thompson; Dipen J Parekh
Journal:  J Urol       Date:  2019-09-24       Impact factor: 7.450

10.  Robot-assisted radical cystectomy is a promising alternative to open surgery in the Japanese population with a high rate of octogenarians.

Authors:  Hideto Iwamoto; Tetsuya Yumioka; Noriya Yamaguchi; Toshihiko Masago; Shuichi Morizane; Masashi Honda; Takehiro Sejima; Atsushi Takenaka
Journal:  Int J Clin Oncol       Date:  2016-01-20       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.